Prevalence of ectopic thymic tissue in myasthenia gravis and its clinical significance

J Thorac Cardiovasc Surg. 1995 Apr;109(4):632-5. doi: 10.1016/S0022-5223(95)70343-8.

Abstract

Forty patients with myasthenia gravis underwent maximal thymectomy. Complete histologic study findings were available for 38 patients. The prevalence of ectopic thymic tissue was 39.5% (15 of 38). On the basis of the presence or absence of ectopic thymic tissue, patients were divided into two groups: group I had ectopic thymic tissue and group II had no ectopic thymic tissue. Male/female ratio was almost equal (1.1:1) in group I, whereas in group II the ratio was 1:2.8. The duration of the disease was less than 1 year in 80% of group I and 47.8% of group II patients (p = 0.05). Furthermore, ectopic thymic tissue (group I) was associated with poor outcome of operation (p = 0.003). Only 2 (13.3%) of 15 patients in group I had complete remission as compared with 11 (47.8%) of 23 patients in group II. Thus it appears that the presence of ectopic thymic tissue not only modifies some of the clinical parameters of myasthenia gravis, but also could serve as a prognostic factor in predicting the outcome of operation.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Choristoma / complications*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myasthenia Gravis / complications*
  • Myasthenia Gravis / surgery
  • Prognosis
  • Thymectomy
  • Thymus Gland*
  • Treatment Outcome